Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.75 USD | -5.41% | +11.96% | +52.38% |
02/05 | NovoCure Shares Steady After Reporting Narrower Q1 Loss, Higher Revenue | MT |
02/05 | BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.38% | 244.82Cr | |
+72.98% | 1.24TCr | |
-20.40% | 776.19Cr | |
+6.24% | 661.02Cr | |
+12.78% | 540.13Cr | |
+38.73% | 495.76Cr | |
-16.79% | 475.04Cr | |
-24.72% | 389.19Cr | |
-29.57% | 265.81Cr | |
-0.74% | 198.02Cr |
- Stock Market
- Equities
- NVCR Stock
- News NovoCure Limited
- Transcript : NovoCure Limited, Q1 2023 Earnings Call, May 04, 2023